The new Product Liability Directive: three life sciences priorities before the 2026 deadline
2026年7月2日
Being a member of the IP/IT team in Warsaw, Bartosz contributes a great deal to supporting national and international clients especially from the Life sciences & healthcare sector. His substantial know-how focuses around legal advice for medical devices, pharmaceutical and food companies, and includes regulatory, market access, product classification and advertising matters, amongst others.
Medical companies rely on his expertise when needing to adapt to the ever-changing medical devices legislation. He has extensive experience in providing legal trainings and workshops to the Life sciences industry and will also support clients on data protection and compliance issues.
最新新闻和观点
International Life Sciences Newsletter - Life Sciences Legal Lens Vol. 2
点击此处了解更多
Poland’s new AI systems act: a regulator and practical tools
Poland’s new AI systems act builds the national framework for the EU AI Act. A new regulator is introduced, alongside two practical tools.
2026年7月2日
Briefing
9 / 9 观点
International Life Sciences Newsletter - Life Sciences Legal Lens Vol 1
点击此处了解更多
Proposed Amendments to the EU Medical Device Regulation
A European Perspective #1 | The Commission’s proposed MDR/IVDR reform introduces substantial changes to certification, classification and compliance frameworks. Medical device companies should assess potential im-pacts early and prepare for a shifting regulatory landscape.
2026年4月15日
Briefing
2 / 9 观点
Online
In Person